as 12-20-2024 4:00pm EST
VolitionRX Ltd is a United States-based epigenetics company that applies its Nucleosomics platform through its subsidiaries to develop simple, easy-to-use, cost-effective blood tests to help diagnose and monitor a range of life-altering diseases including some cancers and diseases associated with NETosis such as sepsis and COVID-19. The tests are based on the science of Nucleosomics, which is the practice of identifying and measuring nucleosomes in the bloodstream or other bodily fluid - an indication that disease is present. The company is focused on human diagnostics and monitoring but also has a subsidiary focused on animal diagnostics and monitoring.
Founded: | N/A | Country: | United States |
Employees: | N/A | City: | HENDERSON |
Market Cap: | 67.2M | IPO Year: | N/A |
Target Price: | $4.17 | AVG Volume (30 days): | 577.3K |
Analyst Decision: | Strong Buy | Number of Analysts: | 4 |
Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
EPS: | -0.36 | EPS Growth: | N/A |
52 Week Low/High: | $0.43 - $1.23 | Next Earning Date: | 11-14-2024 |
Revenue: | $1,285,827 | Revenue Growth: | 97.50% |
Revenue Growth (this year): | 180.66% | Revenue Growth (next year): | 558.69% |
Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
---|---|---|---|---|---|---|---|---|---|
Innes Guy Archibald | VNRX | Director | Dec 9 '24 | Buy | $0.57 | 174,764 | $99,999.96 | 617,085 | |
Micallef Jacob Vincent | VNRX | Chief Scientific Officer | Dec 9 '24 | Buy | $0.57 | 43,691 | $24,999.99 | 394,352 | |
Reynolds Cameron John | VNRX | President and CEO | Dec 9 '24 | Buy | $0.57 | 139,811 | $79,999.85 | 2,117,404 | |
STILL TIMOTHY I | VNRX | Director | Dec 9 '24 | Buy | $0.57 | 87,382 | $49,999.98 | 1,487,382 |
VNRX Breaking Stock News: Dive into VNRX Ticker-Specific Updates for Smart Investing
PR Newswire
9 days ago
PR Newswire
11 days ago
PR Newswire
15 days ago
Zacks Small Cap Research
17 days ago
GuruFocus.com
a month ago
Associated Press Finance
a month ago
PR Newswire
a month ago
GuruFocus.com
a month ago
The information presented on this page, "VNRX VolitionRX Limited - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.